- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Panel studies medication problems of elderly
PHILADELPHIA - The American Society of Consultant Pharmacists will form an independent, interdisciplinary panel with the Alliance for Aging Research to examine medication-related problems in nursing facilities, the association announced at its annual meeting in November.
PHILADELPHIA - The American Society of Consultant Pharmacists will form an independent, interdisciplinary panel with the Alliance for Aging Research to examine medication-related problems in nursing facilities, the association announced at its annual meeting in November.
The panel will prepare a report recommending public policy actions for Congress. The ASCP hopes that policy-makers will strengthen the role of consultant pharmacists as medication experts for the elderly, according to R. Tim Webster, executive director of the ASCP.
According to a study supported by the ASCP's Research and Education Foundation, published in the Oct. 13 issue of Archives of Internal Medicine, the United States saves $3.6 billion annually on medication-related problems, and improves patient outcomes by 43% through pharmacist-conducted drug-regimen reviews in nursing facilities. The study estimated that preventable medication-related problems in nursing homes could cost as much as $7.6 million per year without the intervention of consultant pharmacists. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
